ArticleComputational and structural biotechnology journal2025
OncoProExp: An interactive shiny web application for comprehensive cancer proteomics and phosphoproteomics analysis.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Tumour endothelial cell reprogramming orchestrates angiocrine signalling to drive chemoresistance in breast cancer.Angiogenesis · 2026Article
- Deep learning-based prediction of gene expression from histopathology identifies NR5A1 as a candidate biomarker and druggable target in high-grade serous ovarian carcinoma.Journal of ovarian research · 2026Article
- Explainable machine learning for preoperative relapse prediction in molecularly stratified endometrial cancer: A single-center finnish cohort study.Computational and structural biotechnology journal · 2026Article
- Serum-MiR-CanPred: deep learning framework for pan-cancer classification and miRNA-targeted drug discovery.RNA biology · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer research has been revolutionized by mass spectrometry (MS)-based proteomics, enabling large-scale profiling of proteins and post-translational modifications (PTMs) to identify critical alterations in cancer signaling pathways. However, the lack of comprehensive, user-friendly platforms for integrative analysis limits efficient data exploration, biomarker discovery, and translational insights. To address this, we developed OncoProExp, a Shiny-based interactive web application for in-depth cancer proteomic and phosphoproteomic analyses. OncoProExp offers robust workflows for data preprocessing, interactive visualizations (PCA, hierarchical clustering, heatmaps, gene set enrichment analysis (GSEA)), and functional annotation of gene expression data. Differential expression analysis facilitates biomarker and therapeutic target discovery, while survival analysis identifies proteins whose expression stratifies overall survival, and pan-cancer exploration integrates clinical proteomic and phosphoproteomic datasets. OncoProExp also incorporates state-of-the-art predictive modeling, including Support Vector Machines (SVMs), Random Forests, and Artificial Neural Networks (ANNs) to classify cancer types from proteomic and phosphoproteomic profiles. These models were enhanced by SHapley Additive exPlanations (SHAP) for interpretability. To enhance its translational utility, OncoProExp supports user-uploaded data, protein-protein interactions, pathway enrichment, drug relevance evaluation, and clinical annotation analysis. OncoProExp is deployable via Docker containers, ensuring flexible and scalable integration into individual servers. Its utility has been demonstrated using Clinical Proteomic Tumor Analysis Consortium (CPTAC) datasets. OncoProExp is freely accessible at https://oncopro.cs.ut.ee/ without login requirements, offering a comprehensive resource for translational cancer research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.